NO-1886 upregulates ATP binding cassette transporter A1 and inhibits diet-induced atherosclerosis in Chinese Bama minipigs

This publication has 23 references indexed in Scilit:

• Human ABCA1 BAC Transgenic Mice Show Increased High Density Lipoprotein Cholesterol and ApoAI-dependent Efflux Stimulated by an Internal Promoter Containing Liver X Receptor Response Elements in Intron 1
  Journal of Biological Chemistry, 2001
• The Framingham Study : ITS 50-Year Legacy and Future Promise
  Journal of Atherosclerosis and Thrombosis, 2000
• Nikolaj Nikolajewitsch Anitschkow (1885–1964) established the cholesterol-fed rabbit as a model for atherosclerosis research
  Atherosclerosis, 1997
• Oxidized Lipids in the Diet Accelerate the Development of Fatty Streaks in Cholesterol-Fed Rabbits
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1996
• Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM
  Diabetologia, 1995
• Relationship between HDL-cholesterol and apolipoprotein Al and the severity of coronary artery disease
  European Heart Journal, 1995
• Correction of Hypertriglyceridemia with Low High-Density Lipoprotein Cholesterol by the Novel Compound NO-1886, a Lipoprotein Lipase-Promoting Agent, in STZ-Induced Diabetic Rats
  Diabetes, 1995
• The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis.
  Journal of Clinical Investigation, 1993
• A selective decline of postheparin plasma hepatic triglyceride lipase in hypothyroid rats
  Metabolism, 1980
• Plasma triglyceride transport kinetics in diabetes mellitus
  Metabolism, 1973